|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 278, Issue 44, 43580-43585, October 31, 2003
Kinetic Dissection of Two Distinct Proton Binding Sites in Na+/H+ Exchangers by Measurement of Reverse Mode Reaction*![]() From the Department of Molecular Physiology, National Cardiovascular Center Research Institute, Suita, Osaka 565-8565 Japan
Received for publication, June 24, 2003 , and in revised form, July 24, 2003.
We examined the effect of intracellular acidification on the reverse mode of Na+/H+ exchange by measuring 22Na+ efflux from 22Na+-loaded PS120 cells expressing the Na+/H+ exchanger (NHE) isoforms NHE1, NHE2, and NHE3. The 5-(N-ethyl-N-isopropyl)amiloride (EIPA)- or amiloride-sensitive fraction of 22Na+ efflux was dramatically accelerated by cytosolic acidification as opposed to thermodynamic prediction, supporting the concept that these NHE isoforms are activated by protonation of an internal binding site(s) distinct from the H+ transport site. Intracellular pH (pHi) dependence of 22 Na+ efflux roughly exhibited a bell-shaped profile; mild acidification from pHi 7.5 to 7 dramatically accelerated 22Na+ efflux, whereas acidification from pHi 6.6 gradually decreased it. Alkalinization above pHi 7.5 completely suppressed EIPA-sensitive 22Na+ efflux. Cell ATP depletion and mutation of NHE1 at Arg440 (R440D) caused a large acidic shift of the pHi profile for 22Na+ efflux, whereas mutation at Gly455 (G455Q) caused a significant alkaline shift. Because these mutations and ATP depletion cause correspondingly similar effects on the forward mode of Na+/H+ exchange, it is most likely that they alter exchange activity by modulating affinity of the internal modifier site for protons. The data provide substantial evidence that a proton modifier site(s) distinct from the transport site controls activities of at least three NHE isoforms through cooperative interaction with multiple protons.
The Na+/H+ exchangers (NHEs)1 belong to one of the secondary active transporter families that catalyze the transport of ions or solutes using a driving force generated by active ion pumps. NHEs are involved in various cellular functions such as pH homeostasis, cell volume regulation, and transepithelial Na+ absorption (14), and at least eight isoforms differing in tissue and subcellular localization have been identified. The activities of NHEs are controlled by various extrinsic factors including hormones, growth factors, pharmacological agents, and mechanical stimuli (14). Many of these stimuli modulate the activity by changing the apparent affinity for intracellular H+ (Refs. 58; see Refs. 14 for reviews).
Physiologically, NHE catalyzes an electroneutral exchange of extracellular Na+ for intracellular H+, i.e. a forward mode of exchange with the aid of a constant driving force provided by a Na+ pump. However, NHE is also able to catalyze the exchange of intracellular Na+ for extracellular H+, i.e. a reverse mode of exchange under certain conditions. In cells, NHE is inactivated usually at an intracellular pH (pHi) of
To obtain insight into the modifier role of intracellular H+,in this study we measured pHi dependence of 22Na+ efflux from cells expressing NHE1, NHE2, or NHE3. We found that 22Na+ efflux is dramatically stimulated by intracellular acidification but almost completely inhibited by modest alkalinization (pHi
MaterialsThe amiloride derivative 5-(N-ethyl-N-isopropyl)amiloride (EIPA) was a gift from New Drug Research Laboratories of Kanebo, Ltd. (Osaka, Japan). 22NaCl was purchased from PerkinElmer Life Sciences. All other chemicals were of the highest purity available. Cell Culture and Stable ExpressionA Na+/H+ exchanger-deficient cell line (PS120) (19) and corresponding transfectants were maintained in Dulbecco' s modified Eagle' s medium (Invitrogen) as described (16). Plasmid transfection and selection of cell populations expressing NHE variants were performed as described (16). Construction of Na+/H+ Exchanger MutantsA plasmid carrying cDNA coding for the Na+/H+ exchanger isoforms NHE13 cloned into the mammalian expression vector pECE was described previously (16). The construction of two mutants, G455Q and R440D, was also described previously (20). Gly455 and Arg440 were reported to be located within the putative transmembrane-spanning domain 11 (TM11) and the intracellular loop 5 (IL5) connecting transmembrane domains 10 and 11 (20). Measurement of 22Na+ EffluxSerum-depleted cells in 24-well dishes were loaded with 22Na+ by preincubating them for 30 min at 37 °C in chloride/KCl medium comprising 20 mM Hepes/Tris (pH 7.4), 0.21.2 mM 22NaCl (37 kBq/ml), 1.9140 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM glucose, and 5 µM nigericin. Choline chloride was added to the medium to maintain the total concentration of KCl plus choline chloride at 140 mM. After removal of the radioactive preincubation solution, 22Na+ efflux was started by adding the same choline chloride/KCl medium except that it additionally contained 2 mM ouabain and 100 µM bumetanide but not 22Na+. For the data at zero time, this efflux solution was not added. In some wells, the efflux solution contained 0.1 mM EIPA or 5 mM amiloride. At the times indicated in Figs. 1, 3, and 5, cells were rapidly washed four times with ice-cold PBS to terminate 22Na+ efflux. pHi was calculated from the imposed [K+] gradient by assuming the equilibrium [K+]i /[K+]o and an intracellular [K+] of 120 mM. Data were normalized as to the protein concentration, which was measured with a bicinchoninic assay system (Pierce) using bovine serum albumin as a standard.
Measurement of 22Na+ Uptake22Na+ uptake activity was measured using serum-depleted cells grown in 24-well dishes in the presence or absence of EIPA as described previously (20).
To measure 22Na+ efflux, we first preincubated PS120 cells or their NHE transfectants for 30 min in a radioactive solution containing 1 mM 22NaCl, the K+/H+ ionophore nigericin, and either 48 or 140 mM KCl. This preincubation allowed cells to be pHi-clamped at 7 or 7.5 and, at the same time, to be loaded with 22Na+. 22Na+ was rapidly taken up by cells and reached nearly to the plateau after the preincubation for 20 min under both conditions (Fig. 1B), suggesting that the radioactivity of 22Na+ was equilibrated in the extra- and intracellular medium. The intracellular 22Na+ concentration at 30 min was 12 mM by assuming a value of 5 µl of cell water per milligram of protein. After removal of the preincubation solution, cells were placed in a Na+-free, non-radioactive solution (pH 7.4) to start 22Na+ efflux. By this procedure, we were able to measure 22Na+ efflux in the presence of an outwardly directed H+ gradient (at pHi 7) or in almost the absence of the H+ gradient (at pHi 7.5) (Fig. 1A). We expected that NHE-independent background 22Na+ leakage would be minimal, because the efflux medium contained the Na+-pump inhibitor ouabain and the Na+/K+/Cl cotransporter inhibitor bumetanide but not , a substrate for both cotransporter and Na+-dependent exchanger. In fact, we observed only slow 22Na+ efflux in exchanger-deficient PS120 cells and their NHE1 transfectants in the presence of the NHE-specific inhibitor EIPA (Fig. 1, CE). As expected, EIPA-sensitive 22Na+ efflux was not detectable in exchanger-deficient PS120 cells whose pHi was maintained at 7 (Fig. 1C) or 7.5 (not shown). In NHE1 transfectants, however, rapid EIPA-sensitive 22Na+ efflux was observed at pHi 7 (Fig. 1D), although little EIPA-sensitive 22Na+ efflux was observed at pHi 7.5 (Fig. 1E). Thus, 22Na+ efflux via NHE1 is dramatically stimulated by intracellular acidification, whereas it is completely inhibited by alkalinization. If we assume that NHE1 catalyzes a counter transport reaction only involving the transport site, the outwardly directed H+ gradient should lead to inhibition of 22Na+ efflux. The data support the view that activity of NHE1 is regulated by protonation/deprotonation of the H+ modifier site(s), which is different from the H+ transport site. To examine pHi dependence of 22Na+ efflux, we clamped pHi at various values by incubating NHE1-expressing cells for 30 min in solutions containing nigericin and different concentrations of KCl. Because 22Na+ was taken up by cells via the exchanger during pHi clamping, 22Na+ loading was greater in cells clamped at lower pHi than in cells clamped at higher pHi. To minimize such differences in 22Na+ loading, we used a pHi clamp solution containing different concentrations (0.21.2 mM) of 22NaCl. As shown in Fig. 2A, the level of 22Na+ loading varied from 10 to 16 nmol/mg (corresponding to intracellular concentrations of 23 mM), indicating that the outwardly directed Na+ gradient produced under the conditions used was not very different. Fig. 2A also shows levels of 22Na+ remaining in cells 3 min after the addition of the efflux solution with or without EIPA. We plotted the EIPA-sensitive fraction of 22Na+ efflux (Fig. 2B, open circles), and the values normalized to the initial level of 22Na+ loading as a function of pHi (Fig. 2C). The 22Na+ efflux increased steeply with decreasing pHi from 7.5 to 7.2, reached the maximum at pHi 6.6, and then decreased with decreasing pHi from 6.6 to 5.6. The bell-shaped pHi profile of 22Na+ efflux suggests that there are at least two intracellular proton-binding sites, each involved in the stimulation and inhibition of NHE1 function, respectively.
We examined the effect of cell ATP depletion on the pHi dependence of 22Na+ efflux. We treated cells for 30 min with metabolic inhibitors 2-deoxyglucose (5 mM) and oligomycin (2 µg/ml) during pHi clamping. Such treatment decreased cell ATP to less than 5% of that in normal cells (16). In these cells, the initial 22Na+ loading was 69 nmol/mg (corresponding to intracellular concentrations of 1.21.8 mM) at pHi values from 6.6 to 7.5, although 22Na+ was loaded to high levels (2030 nmol/mg) at pHi 6.2 or 5.6. EIPA-sensitive 22Na+ efflux and its normalized values were plotted against pHi. As shown in Fig. 2, B and C, 22Na+ efflux was almost completely inhibited by ATP depletion at least in the pHi range from 6.6 to 7.5, consistent with the previous finding (16, 2123) that ATP depletion greatly shifts the pHi dependence of the forward mode of Na+/H+ exchange to an acidic side, as shown in Fig. 2D. It is also noted that, similar to the forward mode, the inhibitory effect of ATP-depletion on 22Na+ efflux is alleviated by acidification. Fig. 3 shows the results of similar 22Na+ efflux measurements using cells expressing G455Q or R440D in which the pHi dependence of the forward mode of exchange markedly shifts to alkaline and acidic sides, respectively (Fig. 4B; see also Ref. 20). As in the case with the wild type NHE1, 22Na+ efflux in G455Q-expressing cells was much faster at pHi 7 than at pHi 7.5 (Fig. 3, A and B). Interestingly, a significant level of EIPA-sensitive 22Na+ efflux was still observed in these cells even at pHi 7.5 (Fig. 3B), unlike the case with the wild-type NHE1. In contrast, a significant level of EIPA-sensitive 22Na+ efflux was not observed in R440D-expressing cells at pHi 7 (Fig. 3C) or 7.5 (Fig. 3D), although low levels of 22Na+ efflux were observed in a more acidic range of pHi (Fig. 4A). Fig. 4 shows pHi profiles of 22Na+ efflux in cells expressing G455Q or R440D. The pHi profile was significantly shifted to an alkaline side in G455Q-expressing cells compared with cells expressing the wild-type NHE1 (Fig. 4, A and B). In contrast, the pHi profile was markedly shifted to an acidic side in cells expressing R440D.
Finally, we examined whether intracellular acidification activates 22Na+ efflux in cells expressing NHE2 or NHE3 (Fig. 5). In these experiments, we used a high concentration (5 mM) of amiloride in place of EIPA as an inhibitor, because these isoforms are relatively less sensitive to the amiloride analogue. As in the case of NHE1, modest intracellular acidification (pHi 7) significantly accelerated amiloride-sensitive 22Na+ efflux from cells expressing NHE2 or NHE3, although 22Na+ efflux from NHE2 transfectants was relatively slow (Fig. 5). The slow efflux in NHE2 transfectants may be due to lower expression of the exchanger in the plasma membrane, because exchange activity of these transfectants was 2030% of that of NHE1 or NHE3 transfectants.
In this work we tried to kinetically dissect proton-binding sites in the Na+/H+ exchanger by measuring EIPA-sensitive 22Na+ efflux from cells expressing different NHE isoforms. We loaded cells with 22Na+ while clamping pHi at various values using a K+/nigericin technique and measured 22Na+ efflux at a constant extracellular pH (7.4) in the nominal absence of extracellular Na+. To avoid possible interaction of cytosolic Na+ with the H+ modifier site as suggested previously (14, 25), we limited the extent of 22Na+ loading to low levels (23 mM). To our knowledge, 22Na+ efflux has never been measured using cultured cells under such defined conditions. 22Na+ efflux from cells expressing NHE1, NHE2, or NHE3 was markedly stimulated by cytoplasmic acidification, contrary to the prediction based on reduced H+ concentration gradient. As proposed previously (9, 10), the results can be interpreted as indicating that these NHE isoforms possess the H+ modifier site and that occupancy of the latter by a proton(s) results in activation of exchange activity. We observed that the NHE1-mediated 22Na+ efflux exhibited roughly bell-shaped pHi dependence. Modest cytosolic alkalinization (pHi 7.5) abolished 22Na+ efflux (Figs. 1D, 2B, and 4), whereas modest cytosolic acidification from pHi 7.5 to 77.2 dramatically enhanced it (Figs. 1C, 2B, and 4). The increase in 22Na+ efflux in the latter pHi range was very steep, suggesting the binding of two or more protons to the modifier site. In a near-neutral pHi range, cell ATP depletion or mutations of NHE1 (R440D and G455Q) caused marked shifts in the pHi dependence of 22Na+ efflux (Figs. 2B, 3B, and 4). Because they also caused similar large shifts in pHi dependence of the forward mode of Na+/H+ exchange under corresponding conditions (20), it is most likely that modulation of Na+/H+ exchange by these procedures is attributable to altered interaction of the H+ modifier site with activating protons. On the other hand, acidosis (<pHi 6.2) caused an extensive inhibition of 22Na+ efflux (Figs. 2B and 4). This inhibition appears to result from competition between Na+ and H+ for the intracellular transport site. Our measurement of the descending and ascending slopes of pHi dependence of 22Na+ efflux thus allowed us to observe the binding of protons to the H+ modifier and H+ transport sites, respectively. The effect of pHi on 22Na+ efflux from cells was measured previously using thymic lymphocytes (13) in which a significant difference in 22Na+ efflux was not observed at the two pHi values tested (7.2 and 6.3). A possible explanation for such data is that the two pHi values used for thymic lymphocytes may not be optimal for observing a large pHi-dependent change in 22Na+ efflux. We attempted to reproduce by simulation the pHi dependence of the forward and reverse modes of Na+/H+ exchange and their modulation by ATP depletion or the exchanger mutations using a simplified reaction model and the assumption that three protons (n = 3) cooperatively interact with the modifier site and a single proton interacts with the transport site (Fig. 6, A and B). We were able to at least qualitatively reproduce complex pHi profiles of the forward and reverse modes of exchange and their modulation (Fig. 6, C and D). For example, ATP depletion or mutation of Arg440 inhibited the uptake and efflux activities more strongly in the neutral pHi range (6.67.5). In addition, pHi dependence between 6.6 and 5.6 was very steep when the activity was measured as uptake but not as efflux (Figs. 2 and 4) under ATP depletion or in cells expressing R440D (compare the pHi profiles in Figs. 2, 4 and 6). Thus our measurement of pHi dependence of 22Na+ efflux permitted us to analyze kinetic properties of the H+ modifier site interacting with activating protons. The observed properties are compatible with the predicted roles of the exchanger in cell pHi regulation, i.e. protection of cells from excessive alkalosis, acceleration of recovery of cells from acidosis, and modulation of exchange activity due to alteration in H+ affinity of the modifier site, in particular in the near-neutral pHi range.
Mutation of Arg440 shifts pHi dependence of the forward mode of Na+/H+ exchange toward an acidic side, whereas that of Gly455 shifts it toward an alkaline side without changing apparent affinities for extracellular substrates Na+ and H+ and the inhibitor EIPA (20) (see Fig. 4B). Thus, the present data reinforce our previous conclusion that the region encompassing the intracellular loop IL5 and the transmembrane domain TM11 plays a crucial role in the proper functioning of the H+ modifier site (20). Although the structure of the H+ modifier site is not known, we suggested previously that pHi sensing of NHE1 may be controlled by a substructure consisting of intracellular loop IL5 and the juxtamembrane subdomain I of the cytoplasmic domain (amino acids 503595) with a tightly bound calcineurin B homologous protein (20, 26). In general, a histidine residue has been thought to be a good candidate for a residue involved in pHi sensing, because its imidazole moiety is the only side chain that ionizes in solution within a physiological pH range. Indeed, His225 and His367 have been identified as important residues for pH sensing of the Na+/H+ antiporters of Escherichia coli (NhaA) (27, 28) and Schizosaccharomyces pombe (Sod2) (29, 30), respectively. However, little change was observed in pHi sensitivity when histidine residues at positions 76, 81, 250, 285, 325, 373, 376, 407, 408, and 473 were substituted by cysteine in NHE1,2 although a recent study (31) reported that mutations at His479 and His499 in the juxtamembrane cytoplasmic domain of rabbit NHE3 shifted the pHi profile to an acidic side. Other histidine residues of NHE1, i.e. His35, His120 and His349 in the membrane-spanning segments (32) and those in the histidine cluster (HYGHHH) in the cytoplasmic domain (30), do not appear to directly influence exchange activity.
Although the present results suggest the existence of a H+ modifier site in NHEs, it should be noted that complex kinetic effects of protons on exchanger activation have been reported as follows. (i) Transient kinetic studies of the exchanger using kidney brush border membrane vesicles revealed that the exchanger exhibits cooperativity with respect to the external Na+ concentration when vesicles are acid-loaded (33), suggesting that protonation of the modifier site may change the oligomeric interaction. (ii) Exchange activity of NHE3 (34, 35) or NHE1 (36) is slowly (3 In summary, using cultured cells expressing different NHE isoforms, we obtained evidence for the existence of the H+ modifier site(s) distinguishable from the H+ transport site. Our results suggest that interaction of multiple protons with the modifier site results in a dramatic activation of Na+/H+ exchange in response to modest acidification. Clearly, further work is required to clarify the structure and function of the H+ modifier site, which is a hallmark of NHE regulation.
* This work was supported by Grant-in-Aid on Priority Areas 13142210 and Grant-in-Aid for Scientific Research 14580664 from the Ministry of Education, Science, and Culture of Japan, a grant from the Organization of Pharmaceutical Safety and Research (OPSR) of Japan (Promotion of Fundamental Studies in Health Science), Ministry of Health Labour Sciences research grants, and Research on Advanced Medical Technology Grant nano-001.The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 The abbreviations used are: NHE, Na+/H+ exchanger; pHi, intracellular pH; EIPA, 5-(N-ethyl-N-isopropyl)amiloride.
2 S. Wakabayashi, T. Hisamitsu, T. Pang, and M. Shigekawa, unpublished observations.
This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||